相关实验视频

Updated: Jun 25, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

内甲素向终于准备好了吗?

Francesca Schinzari¹, Manfredi Tesauro², Carmine Cardillo³

¹Department of Aging, Policlinico A. Gemelli IRCCS, Roma, Italy.

Clinical science (London, England : 1979)

|May 24, 2024

概括

内甲素受体对抗性 (ERA) 显示出对治疗诸如抗性高血压和脏疾病等疾病的前景. 新的策略和药物开发正在克服过去的副作用,扩大ERA.

科学领域:

内分泌学在内分泌学.
药理学药理学是指药理学的学科.
心血管医学心血管医学

背景情况:

内甲蛋白家族调节重要的生物功能,并与各种疾病有关.
内甲素受体对抗性 (ERA) 面临临临床翻译挑战,因为副作用如液体保留.

研究的目的:

审查最近在内甲林向策略方面的进展.
要突出扩展的临床应用和正在进行的研究内甲素受体对抗剂 (ERA).

主要方法:

关于内甲蛋白病理生理学和ERA临床试验的当前文献的审查.
分析新兴的治疗策略,包括组合疗法和基于抗体的新方法.

主要成果:

近期试验的良好结果扩大了对抗性动脉高血压和质细胞病变的ERA指示.
目前正在进行的研究正在探索ERA组合用于阻液体和固体瘤,并正在研究基于抗体的疗法.

结论:

更好的理解和新的ERA开发正在振兴临床翻译.
内甲素向策略显示出更广泛的临床应用的潜力,克服了以前的局限性.

关键词:

阻止抗体的抗体.临床试验是指临床试验中的临床试验.内分泌素受体内分泌素受体内分泌素受体它们是内细胞.受体对抗性的受体对抗.

更多相关视频

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...